Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges
2024 · Signal Transduction and Targeted Therapy · 68 citations
https://doi.org/10.1038/s41392-024-01936-8
Y
Yunlong Shan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
705
Citations
13
h-index
16
i10-index
Yunlong Shan is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: Ultrasound and Cavitation Phenomena & Gut microbiota and health & Garlic and Onion Studies. The author has an h-index of 13, co-authored 36 publications.
ORCID: 0000-0002-6954-364XPapers by this author
worksTargeting HIBCH to reprogram valine metabolism for the treatment of colorectal cancer
2019 · Cell Death and Disease · 48 citations
https://doi.org/10.1038/s41419-019-1832-6
Prophylaxis of Diallyl Disulfide on Skin Carcinogenic Model via p21-dependent Nrf2 stabilization
2016 · Scientific Reports · 46 citations
https://doi.org/10.1038/srep35676
Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment
2022 · Acta Pharmaceutica Sinica B · 32 citations
https://doi.org/10.1016/j.apsb.2022.02.014
SBF-1 preferentially inhibits growth of highly malignant human liposarcoma cells
2018 · Journal of Pharmacological Sciences · 10 citations
https://doi.org/10.1016/j.jphs.2018.10.009
Mesenchymal stromal cells restrain the Th17 cell response via L-amino-acid oxidase within lymph nodes
2024 · Cell Death and Disease · 5 citations
https://doi.org/10.1038/s41419-024-07024-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat